Resistance patterns to anti-PD-1 therapy in metastatic melanoma

被引：3
|
作者：
Ozgun, Alpaslan
Sondak, Vernon K.
Markowitz, Joseph
机构：
[1] Univ S Florida, Morsani Coll Med, Moffitt Canc Ctr, Dept Cutaneous Oncol, Tampa, FL USA
[2] Univ S Florida, Morsani Coll Med, Dept Oncol Sci, Dept Cutaneous Oncol, Tampa, FL USA
来源：
CHINESE CLINICAL ONCOLOGY | 2016年 / 5卷 / 06期
关键词：
D O I：
10.21037/cco.2016.08.01
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Patterns of acquired resistance to anti-PD-1 antibodies in patients with metastatic melanoma (MM).
    Lee, Jenny H. J.
    Cooper, Adam James
    Lyle, Megan Kate
    Liniker, Elizabeth
    Menzies, Alexander M.
    Kefford, Richard
    Long, Georgina V.
    Carlino, Matteo S.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [2] Anti-PD-1 Therapy in Melanoma
    Moreno, Blanca Hornet
    Parisi, Giulia
    Robert, Lidia
    Ribas, Anton
    SEMINARS IN ONCOLOGY, 2015, 42 (03) : 466 - 473
  • [3] Antiepidermis autoantibodies induced by anti-PD-1 therapy in metastatic melanoma
    Brunet-Possenti, Florence
    Mignot, Sabine
    Deschamps, Lydia
    Descamps, Vincent
    MELANOMA RESEARCH, 2016, 26 (05) : 540 - 543
  • [4] Autoimmune hemolytic anemia induced by anti-PD-1 therapy in metastatic melanoma
    Kong, Benjamin Y.
    Micklethwaite, Kenneth P.
    Swaminathan, Sanjay
    Kefford, Richard F.
    Carlino, Matteo S.
    MELANOMA RESEARCH, 2016, 26 (02) : 202 - 204
  • [5] Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
    Hugo, Willy
    Zaretsky, Jesse M.
    Sun, Lu
    Song, Chunying
    Moreno, Blanca Homet
    Hu-Lieskovan, Siwen
    Berent-Maoz, Beata
    Pang, Jia
    Chmielowski, Bartosz
    Cherry, Grace
    Seja, Elizabeth
    Lomeli, Shirley
    Kong, Xiangju
    Kelley, Mark C.
    Sosman, Jeffrey A.
    Johnson, Douglas B.
    Ribas, Antoni
    Lo, Roger S.
    CELL, 2016, 165 (01) : 35 - 44
  • [6] Limited-duration anti-PD-1 therapy for patients with metastatic melanoma
    Makela, Siru
    Kohtamaki, Laura
    Laukka, Marjut
    Juteau, Susanna
    Hernberg, Micaela
    ACTA ONCOLOGICA, 2020, 59 (04) : 438 - 443
  • [7] Sarcoidosis Following Anti-PD-1 and Anti-CTLA-4 Therapy for Metastatic Melanoma
    Reddy, Swathi B.
    Possick, Jennifer D.
    Kluger, Harriet M.
    Galan, Anjela
    Han, Dale
    JOURNAL OF IMMUNOTHERAPY, 2017, 40 (08) : 307 - 311
  • [8] Clinical Features of Acquired Resistance to Anti-PD-1 Therapy in Advanced Melanoma
    Wang, Daniel Y.
    Eroglu, Zeynep
    Ozgun, Alpaslan
    Leger, Paul D.
    Zhao, Shilin
    Ye, Fei
    Luke, Jason J.
    Joseph, Richard W.
    Haq, Rizwan
    Ott, Patrick A.
    Hodi, F. Stephen
    Sosman, Jeffrey A.
    Johnson, Douglas B.
    Buchbinder, Elizabeth I.
    CANCER IMMUNOLOGY RESEARCH, 2017, 5 (05) : 357 - 362
  • [9] Lichenoid Dermatitis in Three Patients with Metastatic Melanoma Treated with Anti-PD-1 Therapy
    Joseph, Richard W.
    Cappel, Mark
    Goedjen, Brent
    Gordon, Matthew
    Kirsch, Brandon
    Gilstrap, Cheryl
    Bagaria, Sanjay
    Jambusaria-Pahlajani, Anokhi
    CANCER IMMUNOLOGY RESEARCH, 2015, 3 (01) : 18 - 22
  • [10] Activity and safety of radiotherapy with anti-PD-1 drug therapy in patients with metastatic melanoma
    Liniker, E.
    Menzies, A. M.
    Kong, B. Y.
    Cooper, A.
    Ramanujam, S.
    Lo, S.
    Kefford, R. F.
    Fogarty, G. B.
    Guminski, A.
    Wang, T. W.
    Carlino, M. S.
    Hong, A.
    Long, G. V.
    ONCOIMMUNOLOGY, 2016, 5 (09):
12345